JP Morgan Chase’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $114K | Buy |
7,511
+607
| +9% | +$10.6K | ﹤0.01% | 5761 |
|
|
2025
Q4 | $123K | Hold |
6,904
| – | – | ﹤0.01% | 5778 |
|
|
2025
Q3 | $128K | Sell |
6,904
-1,100
| -14% | -$22.7K | ﹤0.01% | 5763 |
|
|
2025
Q2 | $172K | Sell |
8,004
-159
| -2% | -$3.44K | ﹤0.01% | 5312 |
|
|
2025
Q1 | $201K | Sell |
8,163
-34,654
| -81% | -$856K | ﹤0.01% | 5235 |
|
|
2024
Q4 | $992K | Buy |
42,817
+28,768
| +205% | +$719K | ﹤0.01% | 4640 |
|
|
2024
Q3 | $381K | Buy |
14,049
+274
| +2% | +$8.3K | ﹤0.01% | 5085 |
|
|
2024
Q2 | $396K | Sell |
13,775
-7,240
| -34% | -$222K | ﹤0.01% | 4805 |
|
|
2024
Q1 | $613K | Sell |
21,015
-509
| -2% | -$14.2K | ﹤0.01% | 4660 |
|
|
2023
Q4 | $700K | Sell |
21,524
-31,715
| -60% | -$920K | ﹤0.01% | 4565 |
|
|
2023
Q3 | $1.7M | Sell |
53,239
-3,989
| -7% | -$154K | ﹤0.01% | 3666 |
|
|
2023
Q2 | $2.51M | Buy |
57,228
+10,375
| +22% | +$478K | ﹤0.01% | 3368 |
|
|
2023
Q1 | $2.08M | Buy |
46,853
+4,285
| +10% | +$189K | ﹤0.01% | 3513 |
|
|
2022
Q4 | $1.69M | Buy |
42,568
+716
| +2% | +$29.8K | ﹤0.01% | 3683 |
|
|
2022
Q3 | $1.93M | Sell |
41,852
-760
| -2% | -$37.3K | ﹤0.01% | 3497 |
|
|
2022
Q2 | $1.84M | Buy |
42,612
+36,063
| +551% | +$1.65M | ﹤0.01% | 3618 |
|
|
2022
Q1 | $353K | Sell |
6,549
-7,323
| -53% | -$374K | ﹤0.01% | 4896 |
|
|
2021
Q4 | $831K | Buy |
13,872
+8,663
| +166% | +$539K | ﹤0.01% | 4518 |
|
|
2021
Q3 | $342K | Sell |
5,209
-168
| -3% | -$10.9K | ﹤0.01% | 4935 |
|
|
2021
Q2 | $341K | Sell |
5,377
-12,911
| -71% | -$742K | ﹤0.01% | 4942 |
|
|
2021
Q1 | $892K | Buy |
18,288
+12,459
| +214% | +$598K | ﹤0.01% | 4318 |
|
|
2020
Q4 | $240K | Buy |
5,829
+887
| +18% | +$40.7K | ﹤0.01% | 4747 |
|
|
2020
Q3 | $230K | Buy |
4,942
+866
| +21% | +$40.2K | ﹤0.01% | 4295 |
|
|
2020
Q2 | $178K | Sell |
4,076
-32,651
| -89% | -$1.47M | ﹤0.01% | 4318 |
|
|
2020
Q1 | $1.46M | Buy |
36,727
+14,387
| +64% | +$645K | ﹤0.01% | 3176 |
|
|
2019
Q4 | $1.05M | Buy |
22,340
+11,524
| +107% | +$446K | ﹤0.01% | 3822 |
|
|
2019
Q3 | $382K | Sell |
10,816
-23,602
| -69% | -$818K | ﹤0.01% | 4303 |
|
|
2019
Q2 | $1.33M | Buy |
34,418
+465
| +1% | +$18.7K | ﹤0.01% | 3670 |
|
|
2019
Q1 | $1.5M | Buy |
33,953
+9,164
| +37% | +$349K | ﹤0.01% | 3531 |
|
|
2018
Q4 | $865K | Sell |
24,789
-45,436
| -65% | -$1.44M | ﹤0.01% | 3837 |
|
|
2018
Q3 | $2.57M | Buy |
70,225
+11,931
| +20% | +$365K | ﹤0.01% | 3282 |
|
|
2018
Q2 | $1.55M | Sell |
58,294
-32,392
| -36% | -$691K | ﹤0.01% | 3579 |
|
|
2018
Q1 | $1.37M | Sell |
90,686
-8,041
| -8% | -$142K | ﹤0.01% | 3500 |
|
|
2017
Q4 | $1.9M | Buy |
+98,727
| New | +$1.89M | ﹤0.01% | 3364 |
|
Other funds holding KIDS
B
GIM
VCM
SCM
JP Morgan Chase's KIDS Position: Q1 2026 in Review
JP Morgan Chase increased its OrthoPediatrics (KIDS) stake by 8.8% in Q1 2026, buying an estimated $10.6K and bringing the position to 7,511 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #5761.
JP Morgan Chase first reported a position in KIDS in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.57M in Q3 2018. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.
- JP Morgan Chase held 7,511 shares of OrthoPediatrics worth $114K as of Q1 2026.
- JP Morgan Chase bought 607 OrthoPediatrics shares in Q1 2026, an estimated $10.6K.
- OrthoPediatrics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5761 holding.
- JP Morgan Chase first reported a position in OrthoPediatrics in Q4 2017 and has held it in 34 quarters since.
- JP Morgan Chase's OrthoPediatrics position peaked at $2.57M in Q3 2018.
- 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.